Secondary breast carcinoma after completely remitted chronic myeloid leukemia following targeted tyrosine kinase inhibitor therapy.

This report provides evidence to assist in the diagnosis and treatment for this rare manifestation. PMID: 28585003 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28585003?dopt=Abstract

Source: Breast Cancer - June 5, 2017 Category: Cancer & Oncology Authors: Pan L, Duan J, Qiao W, Bi L, Wu D, Fan Z, Yang M Tags: Breast Cancer Source Type: research